A mysterious RNA found in breast cancer led scientists to uncover an entire hidden class of cancer-specific RNAs across ...

Grail continues facing significant challenges as its stock plummeted over 45% after its landmark NHS-Galleri trial failed to ...

The Primary Endpoint of Statistically Significant Combined Stage III-IV Reduction Was Not Met, However A Favorable Trend Was Observed Over Time GRAIL Announces U.S. Sales Force Expansion Based on ...

Bangladeshi researcher Md Masum Billah is advancing the application of artificial intelligence in healthcare and digital security, focusing on practical solutions for real-world challenges, said a ...

Khaberni - Early cancer detection technologies are undergoing a radical transformation with the emergence of multicancer blood tests (MCED), which rely on the analysis of free DNA ...

A new light-based imaging approach has produced an unprecedented chemical map of the Alzheimer’s brain. Rice University researchers have produced what they describe as the first full, label-free ...

A recent study suggests that a freely available AI tool could help predict dangerous complications after stem cell transplants.

By Priyanjana Pramanik, MSc. Large international cohort data suggest plant-forward eating patterns and certain micronutrients ...

Nikki Romanik and Ashish K Jha propose a new surveillance system to detect and attribute emerging biological threats to enable a rapid public health response Recent advances in bioengineering ...

MENLO PARK, Calif., Feb. 19, 2026 /PRNewswire/ -- GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect cancer early when it can be cured, today reported business and financial ...